Kim A Reiss (Reiss Binder), MD

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0735
Fax: 215-662-4646
BA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Max M. Wattenberg; Kim A. Reiss; Rosemarie Mick; Michael Giannone; Nevena Damjanov; Elizabeth P. Dunphy; Lisa Dicicco; Luis Garcia-Marcano; Thomas Karasic; Emma E. Furth; Andrzej Wojcieszynski; Robert, H. Vonderheide; Edgar Ben-Josef; Gregory L. Beatty : Peripheral blood immune correlates associated with TGF-β inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) in patients with advanced hepatocellular carcinoma (HCC). ASCO Annual Meeting, Chicago, IL (remote due to COVID-19) June 2020.

Kim Reiss Binder: When Isolation is Worse Than Death: Philly oncologist on cancer patients and COVID-19 - Opinion. Philadelphia Inquirer May 2020.

Akram Saad, Jeffrey Goldstein, Ofer Margalit, Einat Schacham-Shmueli, Yaacov R. Lawrence, Yu-Xiao Yang, Kim A. Reiss, Talia Golan, Ronac Mamtani, Naama Halpern, Dan Aderka, Meir Mouallem, Adam Goldstein, Bruce Giantonio, Ben Boursi: Assessing the effects of beta‐blockers on pancreatic cancer risk: A nested case‐control study. Pharmacoepidemiology & Drug Safety Mar 2020.

Erin M. Bange MD, Abigail Doucette MPH, Peter E. Gabriel. MD MS, Florence Porterfield, James J. Harrigan MD PharmD, Robin Wang, Andrez P. Wojcieszynski MD, Ben Boursi MD,2, Bethany I. Mooney CRNP, Kim A. Reiss, MD*, Ronac Mamtani MD MSCE*: Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma JCO Oncology Practice Mar 2020.

James J. Harding; Hooman Yarmohammadi; Kim A. Reiss; Joanne F. Chou; Marinela Capanu; Richard K. Do; Danny N. Khalil; Imane El Dika; Daniel Giardina; Taha Merghoub; William R. Jarnagin; Gregory Nadolski; Joseph P. Erinjeri; Michael C. Soulen; Benjamin Tan; Ghassan K. Abou-Alfa: Nivolumab and drug eluting bead transarterial chemoembolization (deb-TACE): Preliminary results from a phase I study of patients with liver limited hepatocellular carcinoma. ASCO GI Meeting, San Francisco, CA January 2020.

Maarouf A. Hoteit, Andrezj Wojcieszynski, Brian Currie, Matthew H. Levine, Kimberly A. Forde, Kim A. Reiss, Greg Nadolski, Michael C. Soulen, Steve Helmke, Gregory T. Everson, Edgar Ben-Josef: Deterioration in liver function after liver-directed therapy for hepatocellular carcinoma measured by cholate clearance GastroHep 2020.

Ofer Margalit; Einat Shacham-Shmueli; Yu-Xiao Yang; Yaacov R. Lawerence; Kim A. Reiss; Talia Golan; Naama Halpern; Dan Aderka; Bruce Giantonio ; Ronac Mamtani; and Ben Boursi: Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma. The Oncologist 2020.

Takahiro Tsujikawa, Todd Crocenzi, Jennifer Durham, Elizabeth Sugar, Annie Wu, Beth Onners, Julie Nauroth, Robert Anders, Elana Fertig, Daniel Laheru, Kim Reiss, Robert Vonderheide, Andrew Ko, Margaret Tempero, George Fisher, Michael Considine, Ludmila Danilova, Dirk Brockstedt, Lisa Coussens, Elizabeth Jaffee, and Dung Le: Safety, Survival, and Immune Response with GVAX Pancreas and Listeria-mesothelin (CRS-207) with and without Nivolumab for Pancreatic Cancer. Clinical Cancer Research 2020 Notes: In press.

Max Wattenberg, Daniella Asch, Shun Yu, Peter O’Dwyer, Susan Domchek, Katherine Nathanson, Mark Rosen, Gregory L Beatty, Evan Siegelman, and Kim Reiss : Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation British Journal of Cancer Dec 2019.

Ofer Margalit, Ronac Mamtani, Yaacov Lawrence, Yu-Xiao Yang, Bruce Giantonio, Talia Golan, Dan Aderka, Naama Halpern, Kim Reiss, Einat Shacham-Shmueli, Ben Boursi: Post-Operative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy. Clinical Colorectal Cancer Sept 2019.

back to top
Last updated: 09/24/2020
The Trustees of the University of Pennsylvania